ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA
Article
Tsien, Christina, Pugh, Stephanie, Dicker, adam et al. (2019). ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA
. NEURO-ONCOLOGY, 21(Supplement_6), vi20-vi20. 10.1093/neuonc/noz175.075
Tsien, Christina, Pugh, Stephanie, Dicker, adam et al. (2019). ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA
. NEURO-ONCOLOGY, 21(Supplement_6), vi20-vi20. 10.1093/neuonc/noz175.075